Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS: PBSV · Delayed Price · USD
0.700
0.00 (0.00%)
Apr 22, 2024, 3:35 PM EDT - Market closed
Company Description
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.
The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.
Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.
Pharma-Bio Serv, Inc.
| Country | Canada |
| Founded | 1993 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 100 |
| CEO | Victor Sanchez |
Contact Details
Address: Industrial Zone Street 1, Lot 14 Dorado, PR 00646 Puerto Rico | |
| Phone | 787-278-2709 |
| Website | pharmabioserv.com |
Stock Details
| Ticker Symbol | PBSV |
| Exchange | OTCMKTS |
| Fiscal Year | November - October |
| Reporting Currency | USD |
| CIK Code | 0001304161 |
| CUSIP Number | 71711N100 |
| ISIN Number | US71711N1000 |
| Employer ID | 20-0653570 |
| SIC Code | 8742 |
Key Executives
| Name | Position |
|---|---|
| Victor Sanchez | Chief Executive Officer, President and President of European Operations |
| Pedro J. Lasanta | Chief Financial Officer, Vice President of Finance and Administration and Secretary |
| Elizabeth Plaza | Founder and Senior Strategic Consultant |
| Miriam Marrero M.B.A. | Human Resources Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 8, 2024 | ARS | Filing |
| Apr 8, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 18, 2024 | 8-K | Current Report |
| Mar 18, 2024 | 10-Q | Quarterly Report |
| Feb 28, 2024 | 10-K/A | [Amend] Annual report |
| Jan 30, 2024 | 8-K | Current Report |
| Jan 29, 2024 | 10-K | Annual Report |
| Dec 21, 2023 | 8-K | Current Report |
| Sep 14, 2023 | 8-K | Current Report |
| Sep 14, 2023 | 10-Q | Quarterly Report |